Vitamin K Deficiency Bleeding in Newborns: Symptoms & Prevention

A newborn can look healthy, feed normally, and then develop bleeding that nobody can see. Vitamin K deficiency bleeding (VKDB) is the name for dangerous bleeding caused by too little vitamin K — the nutrient the liver needs to make several essential clotting factors.

This rare condition became very uncommon after the United States introduced routine newborn vitamin K injections in the 1961–1962 period. Recent reporting shows that it is beginning to reappear as more families decline or postpone the injection. Two large U.S. studies published in November 2026 linked lower injection rates with more bleeding, including brain bleeds.

This guide explains what VKDB is, how to recognise warning signs, why the injection is recommended, and what parents can do if they are worried.

In brief: A single vitamin K injection shortly after birth is safe and highly effective. A baby who bleeds unexpectedly, bruises easily, becomes unusually pale or sleepy, vomits blood, or passes blood in the stool needs emergency medical assessment — not home treatment.

---

What Is Vitamin K Deficiency Bleeding?

Vitamin K helps the liver make clotting factors II, VII, IX and X. Without enough vitamin K, blood does not clot normally.

Newborns are vulnerable for three main reasons:

1. Very little vitamin K crosses the placenta, so a baby starts life with low liver stores.
2. The newborn gut is still developing. Intestinal bacteria that make some vitamin K are not yet established.
3. Breast milk contains little vitamin K. Exclusively breastfed babies therefore rely heavily on prophylaxis or later dietary vitamin K.

Babies remain at risk until they eat a regular diet with vitamin K and their gut microbiome develops, usually by about 4–6 months. Maternal vitamin K supplements or a vitamin K-rich diet can slightly raise breast-milk levels, but the CDC says this is not enough on its own to replace newborn prophylaxis.

CDC guidance says infants who do not receive the injection are 81 times more likely to develop late-onset VKDB than those who do.

---

The Three Types of VKDB

Late VKDB is the form most often linked to refusal of the newborn injection. According to the CDC, 30–60% of late cases include bleeding inside the brain.

---

Warning Signs: Some Bleeding Is Invisible

The most dangerous feature of VKDB is that a baby may have no obvious warning before a serious bleed begins.

Do not wait for several warning signs. A baby can bleed into the brain without a visible bruise, and a baby who looks pale or unusually sleepy may be losing blood. Call your local emergency number or go to an emergency department immediately.

---

What the New 2026 Studies Found

The New York Times reported on two nationwide studies published on November 5, 2026 — one in JAMA and one in JAMA Pediatrics.

The JAMA study: more than 5.2 million infants

Researchers analysed records from hospitals and clinics in all 50 states and Washington, DC. Among babies born from 2017 through 2025:

• The proportion with no documented intramuscular vitamin K rose from 3.1% to 6.8%.
• Recorded bleeding occurred in 288 per 10,000 births among babies without documented vitamin K, compared with 186 per 10,000 among babies who received it.
• After adjustment for clinical and demographic factors, no documented vitamin K was associated with a 47% higher risk of bleeding during the first six months.
• Intracranial bleeding occurred in approximately 33 per 10,000 births without documented vitamin K, versus about 13 per 10,000 with it.

The researchers estimated one additional bleeding event for approximately every 114 newborns without documented vitamin K. See the original JAMA paper and the Children’s Hospital of Philadelphia summary.

The JAMA Pediatrics study: more than 11 million infants

A separate study using the Cosmos electronic-health-record network examined more than 11 million infants aged 0–6 months:

• The share receiving injectable vitamin K fell from 97.7% in 2017 to 95.0% in 2025.
• The rate of a coded vitamin K-deficiency bleeding diagnosis rose by 347.1%, from 24.0 to 107.4 cases per 100,000 infants.
• The vitamin K deficiency diagnosis rate rose by 215.7%.
• Only 19.2% of babies diagnosed with vitamin K-deficiency bleeding had received vitamin K.
• 2.4% of babies diagnosed with vitamin K-deficiency bleeding also had an intracranial or intracerebral haemorrhage recorded.

The full study is available as “Vitamin K Deficiency and Associated Bleeding in Infants” in JAMA Pediatrics.

An important limitation

These studies used observational electronic health records. They show a strong association and trend; they do not prove that every recorded bleed was caused by the missing injection. Some newborns may have received the injection without it being recorded correctly, and some bleeding may have been coded differently.

Even with those limitations, the findings matter because they are consistent with the known biology, the established effectiveness of prophylaxis and the experience of hospitals now seeing more cases. A missing injection should not be treated as a reason to wait and see.

---

A ProPublica Case Shows Why Emergency Recognition Matters

In a November 8 ProPublica investigation, reporter Duaa Eldeib documented the death of Gwen Biesenbach, an 11-day-old infant in Texas in August 2023.

Gwen developed bleeding from her umbilical cord stump. Her parents had declined the injection after receiving oral vitamin K drops from their midwife. At a freestanding emergency room, staff tried several local measures to control the bleeding, but the nurse reportedly said the facility did not have a vitamin K injection available.

The infant was eventually transferred, and the transport team gave vitamin K and blood-product treatment. By then, however, she had suffered severe blood loss. Gwen died nearly 11 hours after her family first brought her to the emergency room. The medical examiner listed vitamin K deficiency bleeding as the cause of death.

According to ProPublica’s account of the case, the Texas Medical Board later found that the emergency-room physician had failed to recognise a life-threatening vitamin K-dependent bleeding disorder, failed to arrange immediate transfer to a better-equipped paediatric hospital and failed to quantify the amount of blood lost. The physician was ordered to complete additional medical education and notify her employer of the disciplinary action.

The case shows why two safeguards must work together:

1. Newborn prophylaxis helps stop VKDB from developing.
2. Emergency teams must recognise possible VKDB, have vitamin K available, begin urgent treatment and transfer a deteriorating baby without delay.

Gwen’s parents later said that both subsequent daughters received the vitamin K injection.

---

Injection or Oral Drops? Why the Route Matters

Oral vitamin K is used in some countries with carefully designed, repeated-dose programmes. It is not considered an equivalent replacement in the United States.

If a family is considering oral drops instead of the injection, the decision should be discussed with the obstetrician and paediatrician before birth or discharge — not improvised after a baby starts bleeding. Parents should also be told how to report bleeding promptly rather than waiting for the next scheduled dose.

---

Is the Vitamin K Injection Safe?

The vitamin K injection is not a vaccine. It does not contain a pathogen and does not create immunity. It supplies a nutrient that the newborn body cannot yet store in adequate amounts.

The CDC and AAP address common concerns:

• Cancer link: A small 1990 study suggested an association with childhood cancer. Later, larger studies did not confirm it. The CDC states there is no evidence that the vitamin K injection causes childhood cancer.
• Dose size: The dose looks large compared with an adult daily requirement because newborns start with very small stores and need enough to protect them until dietary sources become adequate.
• Injection discomfort: Pain, bruising or swelling can occur. Holding the baby, breastfeeding during the injection and comforting the baby afterwards can help.
• Allergic reaction: Severe allergic reactions are extremely rare. The CDC reports only a single infant allergic reaction in its cited literature.

The benefits of prevention are much larger than the risks of a brief injection. Treating established VKDB may require repeated blood draws, imaging, blood transfusions, clotting-factor replacement, anaesthesia, surgery and intensive care.

---

If Your Baby Is Bleeding: What To Do Now

1. Treat unexplained bleeding as an emergency. Do not wait to see whether it improves overnight.
2. Call emergency services or go to the nearest emergency department immediately. Pale or limp appearance, altered alertness, repeated vomiting, seizures or heavy ongoing bleeding require emergency transport.
3. Do not give oral drops as a substitute for emergency treatment. Suspected VKDB requires clinical assessment, blood tests, imaging and hospital treatment.
4. Tell the clinician whether the baby received vitamin K at birth, which oral doses were given and when. Bring the discharge summary or vaccination record if available.
5. Mention every change — umbilical bleeding, new bruising, blood in stool, vomiting blood, pallor, poor feeding, unusual sleepiness or seizures.
6. Ask for urgent paediatric and neonatal review if the baby is small, premature, exclusively breastfed or has liver or absorption problems.

If a doctor orders coagulation tests such as PT/INR, aPTT, haemoglobin, platelets or a blood group, scanura can explain the report in plain language. It does not diagnose VKDB or replace emergency care.

---

What Hospitals Can Do

The recent reporting highlights several system-level improvements:

• Keep vitamin K immediately available in labour rooms, paediatric units and emergency departments.
• Train emergency staff to include VKDB when assessing an infant with unexplained bleeding.
• Use rapid transfer pathways for a deteriorating newborn who needs neonatal or paediatric intensive care.
• Track vitamin K refusals and local VKDB cases so gaps become visible early.
• Give families clear information about the injection, oral dosing limitations and emergency warning signs.

WOODTV’s November 12 report also stressed the value of respectful counselling. Paediatrician Karen Rose explained that physicians should listen to families’ questions, build trust and clearly share the evidence. Parents deserve to make informed decisions without shame — but the evidence should include the rare outcomes that a rare condition can cause.

---

Key Takeaways

1. Vitamin K helps the liver make clotting factors. Newborns have very small stores and depend on early supplementation.
2. VKDB is uncommon mainly because most newborns receive the injection. Without prophylaxis, the risk rises sharply.
3. The CDC says babies without the injection are 81 times more likely to develop late VKDB.
4. Internal and brain bleeding may have no visible warning. Any unexplained bleeding in a young infant needs urgent assessment.
5. Two 2026 U.S. studies found more bleeding as injection coverage fell. One reported a 347.1% rise in coded VKDB diagnoses.
6. The injection is not a vaccine and has not been shown to cause childhood cancer. Serious allergic reactions are extremely rare.
7. Oral vitamin K is less reliable in the U.S. and is not FDA-approved as a replacement. It requires a clinician-supervised plan and correct follow-up.
8. Prevention and emergency preparedness must work together. The injection prevents most cases; hospitals must diagnose and treat the rest without delay.

---

Sources and Further Reading

• Duaa Eldeib, “An 11-Day-Old Baby Couldn’t Stop Bleeding. For Hours, the ER Didn’t Provide a Critical Vitamin Shot”, ProPublica, Nov. 8, 2026.
• Lauren Henry/KFOR, “Doctors warn parents about risks of declining vitamin K shots for newborns”, WOODTV.com, Nov. 12, 2026.
• Maggie Astor, “Infant Bleeding Surged as Parents Rejected Vitamin K Shots, Studies Find”, The New York Times, Nov. 5, 2026.
• Kristan Scott et al., “Nonreceipt of Newborn Vitamin K and Risk of Bleeding”, JAMA, published online Nov. 5, 2026.
• Elizabeth R. Wolf et al., “Vitamin K Deficiency and Associated Bleeding in Infants”, JAMA Pediatrics, published online Nov. 5, 2026.
• CDC, “About Vitamin K Deficiency Bleeding” and “Frequently Asked Questions About Vitamin K Deficiency Bleeding”, updated Jan. 17, 2025.
• American Academy of Pediatrics, “Vitamin K Helps Prevent Dangerous Bleeding Disorders in Newborns”, updated May 26, 2026.

---

Disclaimer: This article is for educational purposes only. scanura does not provide medical diagnosis. Always consult your doctor for medical decisions.